Phase 1 Infectious Disease Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
PharmacologyInfectious Disease
Institut National de la Santé Et de la Recherche Médicale, France39 enrolled1 locationNCT06024421
Recruiting
Phase 1
Clinical Trial of PCV24 in Infants Aged 2-23 Months
Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.180 enrolled2 locationsNCT06800261
Recruiting
Phase 1
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
Infectious DiseasesAntimicrobial Drug Resistance
Bugworks Research Inc.48 enrolled1 locationNCT07029932
Recruiting
Phase 1
An Open Label, Adaptive Design Evaluation, Crossover Study of the Safety, Pharmacokinetics and Pharmacodynamics of Various RECCE®327 Intravenous Dose and Infusion Rates
Life threatening infectious diseaseUrinary Tract Infection
Recce Pharmaceuticals Ltd16 enrolled2 locationsACTRN12623000448640